Back

Select your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Arrange a consultation about stem cells

Learn more

Get in touch with us today!

Would you like to find out more about our services? Fill out the form below and we will contact you as soon as possible to provide you with all the necessary information and answer your questions.

    We would like to point out that the personal data provided in the form will be processed by FamiCord Suisse, based in Switzerland (BusinessPark Zug Sumpfstrasse 26, 6302 Zug), for the purpose of contacting you by telephone in connection with the provision of service information.

    Image

    List of life saving
    transplantations

    List of uses for stem cells approved by the FamiCord Group’s laboratories:

    Image
    List of uses for stem cells approved by the FamiCord Group’s laboratories:
    Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
    1401 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 21
    1402 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Denmark 65
    1403 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Romania 25
    1404 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 27
    1405 Apheresis Allogeneic Polycythaemia Vera Hematology 2025 Standard Therapy Germany 61
    1406 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 25
    1407 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 51
    1408 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 70
    1409 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 53
    1410 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Lithuania 61
    1411 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Russian Federation 49
    1412 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 36
    1413 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 62
    1414 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 54
    1415 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 74
    1416 Apheresis Allogeneic NHL Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Poland 49
    1417 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 62
    1418 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2025 Standard Therapy USA 74
    1419 Apheresis Allogeneic NHL Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy Argentine 57
    1420 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 56
    1421 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Belgium 71
    1422 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Spain 59
    1423 Apheresis Allogeneic Other Myelofibrosis/Myelosclerosis Hematology 2025 Standard Therapy USA 65
    1424 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 14
    1425 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Denmark 57
    1426 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 68
    1427 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 51
    1428 Apheresis Allogeneic Richter Transformation CDLBCC Hematology 2025 Standard Therapy Germany 68
    1429 Apheresis Allogeneic Acute Myelogenous Leukemia-MR Hematology 2025 Standard Therapy Russian Federation 16
    1430 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 63
    1431 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 66
    1432 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 50
    1433 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 38
    1434 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 43
    1435 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 74
    1436 Apheresis Allogeneic T-cell Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 51
    1437 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 59
    1438 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 66
    1439 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 68
    1440 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 33
    1441 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 48
    1442 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Netherlands 66
    1443 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 57
    1444 Apheresis Allogeneic Chronic Myelogenous Leukemia Hematology 2025 Standard Therapy Belgium 56
    1445 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 55
    1446 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 24
    1447 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 61
    1448 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 71
    1449 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Canada 53
    1450 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 62
    1451 Apheresis Autologous Mantle Cell Lymphoma Hematology 2025 Standard Therapy Germany 45
    1452 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 61
    1453 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 32
    1454 Apheresis Autologous Diffuse Large B-Cell Lymphoma Hematology 2025 Standard Therapy Germany 62
    1455 Apheresis Autologous Central Nervous System Lymphoma Hematology 2025 Standard Therapy Germany 75
    1456 Apheresis Autologous Multiple Myeloma Hematology 2025 Standard Therapy Germany 70
    1457 Cord Tissue Autologous Autism Neurology 2024 Experimental Therapy Romania 6
    1458 Cord Tissue Allogeneic – Related Autism Neurology 2024 Experimental Therapy Romania 6
    1459 Cord Tissue Autologous Autism Neurology 2024 Experimental Therapy Romania 4
    1460 Cord Tissue Allogeneic – Related Autism Neurology 2024 Experimental Therapy Romania 6
    1461 Cord Tissue Allogeneic – Unrelated Degenerative and Traumatic Cartilage Orthopedics 2024 Experimental Therapy Poland 50,3
    1462 Cord Tissue Allogeneic – Unrelated Degenerative and Traumatic Cartilage Orthopedics 2024 Experimental Therapy Poland 49,5
    1463 Cord Tissue Allogeneic – Unrelated Degenerative and Traumatic Cartilage Orthopedics 2024 Experimental Therapy Poland 58,11
    1464 Cord Tissue Allogeneic – Unrelated Graft Versus Host Disease Hematology 2024 Experimental Therapy Poland 7,7
    1465 Cord Tissue Allogeneic – Unrelated Graft Versus Host Disease Hematology 2024 Experimental Therapy Poland 15,7
    1466 Cord Tissue Allogeneic – Unrelated Ovarian Dysfunction Gynecology 2024 Experimental Therapy Poland 48,1
    1467 Cord Tissue Allogeneic – Related Severe Pulmonary Hypertension +Mitral Regurgitation Cardiovascular/Pulmonary 2024 Experimental Therapy Romania 2,6
    1468 Cord Tissue Allogeneic – Unrelated Amyotrophic lateral sclerosis Neurology 2024 Experimental Therapy Poland 57,6
    1469 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2024 Experimental Therapy Poland 68,2
    1470 Cord Tissue Allogeneic – Related Autism Neurology 2024 Experimental Therapy Romania 17
    1471 Cord Tissue Autologous Autism Neurology 2024 Experimental Therapy Romania 7
    1472 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2024 Experimental Therapy Poland 61,9
    1473 Cord Tissue Allogeneic – Unrelated Degenerative and traumatic cartilage damage Orthopedics 2024 Experimental Therapy Poland 45,4
    1474 Cord Tissue Allogeneic – Unrelated Amyotrophic lateral sclerosis Neurology 2024 Experimental Therapy Poland 56,9
    1475 Cord Tissue Allogeneic – Unrelated Graft-versus-host disease Hematology 2024 Experimental Therapy Poland 0,10
    1476 Cord Tissue Allogeneic – Unrelated Amyotrophic lateral sclerosis Neurology 2024 Experimental Therapy Poland 39,0
    1477 Cord Tissue Allogeneic – Unrelated GvHD Neurology 2024 Experimental Therapy Poland 9,2
    1478 Cord Tissue Allogeneic – Unrelated Cerebral palsy Neurology 2024 Experimental Therapy Poland 5,11
    1479 Cord Tissue Allogeneic – Unrelated Cerebral palsy Neurology 2024 Experimental Therapy Poland 13,10
    1480 Cord Tissue Allogeneic – Unrelated Leukodystrophy Neurology 2024 Experimental Therapy Poland 1,9
    1481 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2024 Experimental Therapy Poland 7,11
    1482 Cord Tissue Allogeneic – Unrelated Leukodystrophy Neurology 2024 Experimental Therapy Poland 1
    1483 Cord Tissue Allogeneic – Unrelated Cerebellar-spinal ataxia Neurology 2024 Experimental Therapy Poland 35,5
    1484 Cord Tissue Allogeneic – Unrelated Leukodystrophy Neurology 2024 Experimental Therapy Poland 1,9
    1485 Cord Tissue Allogeneic – Unrelated Cerebral Palsy Neurology 2024 Experimental Therapy Poland 4,5
    1486 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Romania 11
    1487 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Romania 10
    1488 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Romania 6
    1489 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Romania 4
    1490 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Romania 5
    1491 Cord Blood Allogeneic Cerebral Palsy Neurology 2024 Experimental Therapy Poland 3,5
    1492 Cord Blood Allogeneic Cerebral Palsy Neurology 2024 Experimental Therapy Poland 7,7
    1493 Cord Blood Autologous CP Neurology 2024 Experimental Therapy Hungary 4
    1494 Cord Blood Autologous Pervasive Developmental Disorder Neurology 2024 Experimental Therapy Poland 3,7
    1495 Cord Blood Autologous Pervasive Developmental Disorder Neurology 2024 Experimental Therapy Poland 5,9
    1496 Cord Blood Autologous Pervasive developmental disorder Neurology 2024 Experimental Therapy Poland 4,8
    1497 Cord Blood Allogeneic – Related fanconi aplastic anemia Hematology 2024 Standard Therapy Turkey 12
    1498 Cord Blood Autologous Neuroblastoma Neurology 2024 Standard Therapy Poland 4
    1499 Cord Blood Autologous Pervasive developmental disorder Neurology 2024 Experimental Therapy Poland 9,9
    1500 Cord Blood Autologous Autism Neurology 2024 Experimental Therapy Slovakia 4